Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine(Stem Pharm)

重组九价（6/11/16/18/31/33/45/52/58型）人乳头瘤病毒疫苗(Stem Pharm)

Report date: 2022/12/24 20:00:29

Base Information

Drug NameRecombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine(Stem Pharm)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesiaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Stem Pharmaceutical Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Stem Pharmaceutical Development Co LtdBeijing Health Guard Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A